Angiogenesis, Exudation, and Degeneration 2024 virtual meeting
February 3, 2024 3:30 PM EST
Title: KSI-501 Bispecific Anti-VEGF Anti-IL-6 Antibody Biopolymer Conjugate: First Time Results of the Multiple Ascending Dose Phase 1 Study
Presenter: Mark R. Barakat, M.D., Managing Partner and Director of Clinical Research, Retina Macula Institute of Arizona, Clinical Assistant Professor of Ophthalmology, University of Arizona College of Medicine, Phoenix, AZ
Supporting Materials
View Presentation 1.6 MB